Frank, Rimerman Advisors LLC

Position in MRK — Merck & Co., Inc.

CIK 1977560 Palo Alto, CA

Position in MRK

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$4,845,735

+$353,385 QoQ

Shares Held

37,710

+1.0% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.32%

of 13F equity value

Holder Rank

#1,060

of 3,769 holders

Holding Since

Mar 2021

15 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Frank, Rimerman Advisors LLC holds $61,050,050 across 13 Drug Manufacturers - General names. MRK ranks #4 (7.9% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	11,066	$13,272,893
2	JNJ	Johnson & Johnson	51,668	$13,122,121
3	ABBV	AbbVie Inc.	34,526	$8,688,122
4	MRK	Merck & Co., Inc. This page	37,710	$4,845,735
5	GILD	Gilead Sciences, Inc.	35,286	$4,458,033
6	PFE	Pfizer Inc	164,115	$3,951,889
7	BMY	Bristol Myers Squibb Co	50,290	$2,897,709
8	AMGN	Amgen Inc	7,272	$2,633,336

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$4,845,735	37,710	+1.0%	Shares	Sole	2026-07-27
2026-03-31	$4,492,350	37,346	+6.2%	Shares	Sole	2026-04-29
2025-12-31	$3,700,941	35,160	+1.9%	Shares	Sole	2026-01-15
2025-09-30	$2,894,997	34,493	+19.2%	Shares	Sole	2025-11-04
2025-06-30	$2,290,573	28,936	+61.8%	Shares	Sole	2025-08-11
2025-03-31	$1,605,088	17,882	-22.2%	Shares	Sole	2025-05-12
2024-12-31	$2,285,553	22,975	+68.2%	Shares	Sole	2025-02-10
2024-09-30	$1,551,229	13,660	-57.2%	Shares	Sole	2024-10-24
2024-06-30	$3,946,620	31,879	+7418.6%	Shares	Sole	2024-08-13
2024-03-31	$55,946	424	0.0%	Shares	Sole	2024-05-09
2023-12-31	$46,224	424	-85.5%	Shares	Sole	2024-02-13
2022-03-31	$239,750	2,922	+1.0%	Shares	Sole	2023-09-07
2021-12-31	$221,796	2,894	+6.6%	Shares	Sole	2023-09-07
2021-09-30	$203,848	2,714	-27.7%	Shares	Sole	2023-09-07
2021-03-31	$289,550	3,756	—	Shares	Sole	2023-09-13
No filing history on record for this holder in this stock.